Skip to content

Red Blood Cell Distribution Width and Charlson Comorbidity Indeces in the Frail Polytraumatized Patient.

RDW and CCI in the Frail Polytraumatized Patients. A Retrospective Cohort Study in a Level 1 Trauma Center.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05221476
Enrollment
400
Registered
2022-02-03
Start date
2012-01-31
Completion date
2015-12-31
Last updated
2024-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polytrauma, Red Blood Cell Distribution Width, Comorbidities and Coexisting Conditions

Brief summary

In this study patients who were admitted to our hospital with critical injuries were enrolled retrospectively from January 2012 to December 2015. Patients with an ISS\>16 points, an AIS \>3 in one body region and at least 2 different body regions affected were included. RDW values on admission as well as preexisting comorbidities were evaluated.

Interventions

The investigators retrospectively analyzed the short- and long-term outcome in polytraumatized patients and the possible influence of RDW values on admission as well as preexisting comorbidities on these outcomes.

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ISS \>16 points * AIS \>3 in one body region * at least 2 body regions affected

Exclusion criteria

* patients younger than 18 years of age * isolated traumatic brain injury * minor injuries (AIS \<3 or ISS \<16 points)

Design outcomes

Primary

MeasureTime frame
In-hospital mortality in polytraumatized patientsJanuary 2012 to December 2015

Secondary

MeasureTime frameDescription
Possible influence of RDW values (%) on admission on the long-term outcomeJanuary 2012 to December 2015The influence of RDW Values (%) in polytraumatized patients on admission on the long-term outcome (late-phase death (days)) will be examined.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026